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Abstract 
Background: Vomiting is a common complication after endoscopic procedures in children. Different 
medications could be administered to control vomiting after endoscopy. The goal of this study is to evaluate 
anti-emetic effects of ondansetron in children who undergo endoscopic procedures. 
Methods: In this clinical randomized trial, 198 children (103 female/95 male) were randomly assigned into one 
of the following two studied groups. Case group (G1): Fentanyl 1 µg/kg + propofol 2.5 mg/kg + ondansetron 
0.15 mg/kg and control group (G2): Fentanyl 1 µg/kg + propofol 2.5 mg/kg + 2 cc normal saline. 
Results: The mean age was 6.3 ± 3.5 years (6.2 ± 3.6 years in G1 vs. 6.4 ± 3.5 years in G2). The most common cause 
of endoscopy procedure in both groups was hematochezia. Vomiting, recovery time, Paediatric Anesthesia 
Emergence Delirium (PAED), and Aldrete scores were compared. Rate of vomiting after recovery and Aldrete score 
were significantly different between the two groups. 
Conclusions: Ondansetron is effective in controlling vomiting after colonoscopy and upper gastrointestinal 
endoscopic procedures. Also, patients in intervention group experienced better recovery time. 
© 2017 Tehran University of Medical Sciences. All rights reserved. 
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Introduction 
Endoscopic procedures are becoming more frequent 
procedure for gastrointestinal (GI) tract evaluation (1) 
which are mostly performed outside the operating room 
to reduce cost and dis-availability (2). Although in 
some cases general anesthesia is recommended, 
intravenous sedation is considered as a safe and 
effective method for endoscopic procedure in children 
(3). Ketamine is an N-methyl-D-aspartate receptor 
antagonist. As it has analgesic and anti-hyperalgesic 
effects, it could be used as sedation medication for 
endoscopic procedures in children (4). Midazolam is a 
short-acting benzodiazepine which is used as a sedative 
agent for endoscopic procedures in children (1). 
Thiopental is a short-acting barbiturate general 
anesthetic. In out room endoscopic procedures, it is 
used for analgesic and anesthetic purposes (5). 
Vomiting is a common complication after 
administration of these medications and endoscopic 
procedures. Adding antiemetic agents will help reduce 
the rate of post-procedural vomiting (6). Patients at risk 
of developing post-operative nausea and vomiting 
(PONV) have to receive prophylactic doses of 
antiemetic drugs. One of the best methods for the 
prevention of PONV is to preemptively or preventively 
administrate prophylactic antiemetic drugs (7,8). These 
drugs are, more often than not, expensive and bring 
about certain adverse effects, hence the fact that the 
chosen drug must have minimal side effects and the 
ability to reduce nausea and vomiting (9,10). 
Ondansetron is a 5-hydroxytryptamine receptor (5-HT) 
antagonist with confirmed antinausea and antivomiting 
effects which does not result in sedation, euphoria, 
restlessness, dryness of mouth, tachycardia, mydriasis, 
and urine retention, and does not have extrapyramidal 
side effects (11). It is not commonly used in endoscopic 
procedures in children. Hence, we designed this study to 
evaluate the antiemetic effects of ondansetron in 
children who undergo endoscopic procedures. 
 
Materials and Methods 
This randomized clinical trial (RCT) was conducted on 
patients who referred to Children Medical Center 
(affiliated hospital of Tehran University of Medical  
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Table 1. Demographic characteristics and endoscopy-related factors in two groups 
Variables Ondansetron group Control group P-value 
Age (years) 6.2 ± 3.6 6.4 ± 3.5 0.732 
Sex (%) 
   
Male 46 (46.9) 49 (49) 0.900 
Female 52 (53) 51 (51) 
 
Procedure (%) 
   
Upper GI endoscopy 68 (69.3) 29 (29) 
 
Colonoscopy 30 (31.6) 71 (71) 0.125 
Vomiting after procedure (%) 3 (3) 17 (17) 0.001 
Recovery time 32.0 ± 6.8 35.7 ± 11.8 0.090 
PAED score 18.4 ± 1.2 18.1 ± 1.5 0.100 
Aldrete score 9.40 ± 0.06 9.2 ± 0.8 0.020 
PAED: Paediatric Anesthesia Emergence Delirium; GI: Gastrointestinal 
 
Sciences) in the first 6 months of 2016. A total of 198 
patients (mean age: 6.3 ± 3.5 years), of American 
Society of Anesthesiologists (ASA) Class I or II, 
scheduled for elective gynecologic laparoscopy with 
general anesthesia were enrolled in the study. 
Exclusion criteria included congenital disorders, 
allergy to administered medications, infection of the 
larynx, behavioral disorders, and psychological 
disorders. Moreover, patients who used hypnotic 
medications before entry to endoscopic room were 
excluded from the study. An expert technician, by means 
of block randomization, allocated cases into two groups: 
Group 1: fentanyl 1 µg/kg + propofol 2.5 mg/kg + 
ondansetron 0.15 mg/kg and Group 2: fentanyl 1 µg/kg 
+ propofol 2.5 mg/kg + 2 cc normal saline. 
Neither the physician nor the patients were blinded. 
Cardiopulmonary monitoring was continuous throughout 
the procedure. All parents were asked to fill informed 
consent forms before study although the study had been 
approved by the local Ethics Committee. After 
endoscopic procedure, patients were admitted in 
recovery room, and vomiting, Paediatric Anesthesia 
Emergence Delirium (PAED), and Aldrete scores were 
recorded by a blind technician. 
Data are expressed as mean ± standard deviation, 
number, proportion, or percentage. Statistical analysis was 
performed by SPSS software (version 13, SPSS Inc., 
Chicago, IL, USA). The frequencies of vomiting and 
nausea and the proportions of ASA class were compared 
using the chi-square test or Fisher’s exact test with 
Bonferroni correction. One-way analysis of variance was 
used to compare the age, weight, duration of surgery, and 
fentanyl consumption among the six groups. P < 0.050 
was considered statistically significant.  
 
Results 
In this RCT, 200 children who were candidates for 
colonoscopy and upper GI endoscopic procedures were 
randomly assigned into one of the two studied groups. 
Two parents of children in ondansetron group 
withdrew from the study. And, 198 individuals (103 
female/95 male) remained in the study, 98 cases in case 
group (G1) (fentanyl 1 µg/kg + propofol 2.5 mg/kg + 
ondansetron 0.15 mg/kg) and 100 cases in control 
group (G2) (fentanyl 1 µg/kg + propofol 2.5 mg/kg + 2 
cc normal saline). The mean age was 6.3 ± 3.5 years 
(6.2 ± 3.6 years in G1 vs. 6.4 ± 3.5 years in G2).  
Rate of vomiting after recovery and Aldrete score 
were significantly different between the two groups  
(P < 0.001) (Table 1). In addition, the two groups had a 
statistically significant difference in recovery time and 
Aldrete score variables (P = 0.090 and P = 0.020, 
respectively). Regarding other investigated variables 
including age, sex, type of used procedures, and PAED 
score, there was no significant difference between 
cases and controls. Also, we have compared the 
underlying disease in the two groups to check the 
uniformity of the conditions and comparability of the 
results (Table 2).  
 
Table 2. Underlying disease in the two studied groups 
Type of disease 
Groups 
Total 
Cases Controls 
Achalasia 5 9 14 
Chronic abdominal pain 32 26 58 
Chronic vomiting and nausea 2 1 3 
FTT 1 0 1 
GERD 3 1 4 
IBD 2 6 8 
Hematemesis 13 11 24 
Caustic ingestion and foreign bodies 2 2 4 
Hematochezia 37 41 78 
R/O celiac 1 3 4 
Esophageal 1 0 1 
Total 98 100 198 
GERD: Gastroesophageal reflux disease; IBD: Inflammatory bowel disease; FTT: Failure to thrive 
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Based on the obtained results of the present study, 
there was no statistical difference between the two groups. 
 
Discussion 
The result of the current study showed that ondansetron 
is effective in reducing post-endoscopic vomiting (3 vs. 
17), and recovery time was significantly lower in 
ondansetron group compared to control group (32 vs. 
35, respectively) (P = 0.090). In a previous study, 
Denewa et al. added oral ondansetron to the routine 
management of dehydration and reported lesser 
number of vomiting in ondansetron group. In 
Freedman et al’s. (6) study, 215 children who referred 
due to gastroenteritis were randomly assigned to 
ondansetron and control groups. Their findings showed 
that vomiting rate was 14% in ondansetron group and 
35% in control group (P = 0.010) while the mean 
duration of hospitalization was significantly lower in 
ondansetron group (6). Totally 145 children with 
vomiting during the last year were randomly assigned 
to ondansetron or placebo groups. The rate of vomiting 
was 0-2 in ondansetron and 0-7 in placebo groups (7). 
Stork et al. evaluated 166 children who had vomiting at 
least three times during 24 hours and assigned them to 
normal saline, dexamethasone, and ondansetron 
groups. The results showed that, after administration of 
the drugs, the rate of vomiting was significantly lower 
in ondansetron group (P = 0.020). 
By means of endoscopic procedures, diagnostic and 
therapeutic goals for GI evaluation purposes become 
possible. Medications which are used for sedation before 
endoscopic procedures have side effects such as nausea, 
vomiting, and longer hospitalization. Ondansetron is a 5-
HT subtype 3 receptor antagonist which has antiemetic 
effects (8). It is tolerated well and is effective in 
controlling nausea and vomiting with less adverse effects. 
Other antiemetic medications such as promethazine, 
prochlorperazine, and metoclopramide have several 
adverse effects such as extrapyramidal reactions, lethargy, 
respiratory depression, and cardiac dysrhythmias. 
Our results showed that it is effective in controlling 
post-endoscopic vomiting. As a conclusion, 
ondansetron is effective in controlling vomiting after 
endoscopic procedures. 
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